HENDERA
831152
Hengerda New Materials
300946
Fujian Nebula Electronics.,Ltd
300648
4
HNAC Technology
300490
5
Cubic Digital Technology
300344
US Stock MarketDetailed Quotes
CDT Conduit Pharmaceuticals
- 1.640
- +0.010+0.61%
Close Feb 14 16:00 ET
- 1.540
- -0.100-6.10%
Post 20:01 ET
5.97MMarket Cap-0.09P/E (TTM)
1.670High1.550Low761.87KVolume1.610Open1.630Pre Close1.24MTurnover25.13%Turnover RatioLossP/E (Static)3.64MShares392.00052wk High-0.66P/B4.97MFloat Cap1.45052wk Low--Dividend TTM3.03MShs Float2500.000Historical High--Div YieldTTM7.36%Amplitude1.450Historical Low1.630Avg Price1Lot Size
About Conduit Pharmaceuticals Company
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in Naples, FL.
Company Profile
SymbolCDT
Company NameConduit Pharmaceuticals
Listing DateMar 28, 2022
CEOMr. David Tapolczay
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address4581 Tamiami Trail North,Suite 200
CityNaples
ProvinceFlorida
CountryUnited States of America
Zip Code34103
Phone1-646-491-9132
Websitehttp://www.conduitpharma.com
Company Executives
- Name
- Position
- Salary
- David Tapolczay
- Chief Executive Officer and Director
- 1.34M
- James Bligh
- Director, Senior Vice President, Strategy and Interim Chief Financial Officer
- --
- Dr. Freda C. Lewis-Hall,M.D.
- Chairman of the Board
- 275.31K
- Dr. Andrew James Regan
- Director
- 842.08K
- Simon Fry
- Director
- --
- Faith L. Charles
- Independent Director
- 267.43K
- Chele Chiavacci Farley
- Independent Director
- 268.93K
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025